Table of Contents Executive Summary 1 Industry Overview of Myasthenia Gravis Drugs 1.1 Definition of Myasthenia Gravis Drugs 1.2 Myasthenia Gravis Drugs Segment by Type 1.2.1 Global Myasthenia Gravis Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Anticholinesterases 1.2.3 Immunosuppressants 1.2.4 Intravenous Immune Globulins 1.3 Myasthenia Gravis Drugs Segment by Applications 1.3.1 Global Myasthenia Gravis Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Hospitals 1.3.3 Clinics 1.4 Global Myasthenia Gravis Drugs Overall Market 1.4.1 Global Myasthenia Gravis Drugs Revenue (2014-2025) 1.4.2 Global Myasthenia Gravis Drugs Production (2014-2025) 1.4.3 North America Myasthenia Gravis Drugs Status and Prospect (2014-2025) 1.4.4 Europe Myasthenia Gravis Drugs Status and Prospect (2014-2025) 1.4.5 China Myasthenia Gravis Drugs Status and Prospect (2014-2025) 1.4.6 Japan Myasthenia Gravis Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Myasthenia Gravis Drugs Status and Prospect (2014-2025) 1.4.8 India Myasthenia Gravis Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Myasthenia Gravis Drugs 2.3 Manufacturing Process Analysis of Myasthenia Gravis Drugs 2.4 Industry Chain Structure of Myasthenia Gravis Drugs 3 Development and Manufacturing Plants Analysis of Myasthenia Gravis Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Myasthenia Gravis Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Myasthenia Gravis Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Myasthenia Gravis Drugs Production and Capacity Analysis 4.2 Myasthenia Gravis Drugs Revenue Analysis 4.3 Myasthenia Gravis Drugs Price Analysis 4.4 Market Concentration Degree 5 Myasthenia Gravis Drugs Regional Market Analysis 5.1 Myasthenia Gravis Drugs Production by Regions 5.1.1 Global Myasthenia Gravis Drugs Production by Regions 5.1.2 Global Myasthenia Gravis Drugs Revenue by Regions 5.2 Myasthenia Gravis Drugs Consumption by Regions 5.3 North America Myasthenia Gravis Drugs Market Analysis 5.3.1 North America Myasthenia Gravis Drugs Production 5.3.2 North America Myasthenia Gravis Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Myasthenia Gravis Drugs Import and Export 5.4 Europe Myasthenia Gravis Drugs Market Analysis 5.4.1 Europe Myasthenia Gravis Drugs Production 5.4.2 Europe Myasthenia Gravis Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Myasthenia Gravis Drugs Import and Export 5.5 China Myasthenia Gravis Drugs Market Analysis 5.5.1 China Myasthenia Gravis Drugs Production 5.5.2 China Myasthenia Gravis Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Myasthenia Gravis Drugs Import and Export 5.6 Japan Myasthenia Gravis Drugs Market Analysis 5.6.1 Japan Myasthenia Gravis Drugs Production 5.6.2 Japan Myasthenia Gravis Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Myasthenia Gravis Drugs Import and Export 5.7 Southeast Asia Myasthenia Gravis Drugs Market Analysis 5.7.1 Southeast Asia Myasthenia Gravis Drugs Production 5.7.2 Southeast Asia Myasthenia Gravis Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Myasthenia Gravis Drugs Import and Export 5.8 India Myasthenia Gravis Drugs Market Analysis 5.8.1 India Myasthenia Gravis Drugs Production 5.8.2 India Myasthenia Gravis Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Myasthenia Gravis Drugs Import and Export 6 Myasthenia Gravis Drugs Segment Market Analysis (by Type) 6.1 Global Myasthenia Gravis Drugs Production by Type 6.2 Global Myasthenia Gravis Drugs Revenue by Type 6.3 Myasthenia Gravis Drugs Price by Type 7 Myasthenia Gravis Drugs Segment Market Analysis (by Application) 7.1 Global Myasthenia Gravis Drugs Consumption by Application 7.2 Global Myasthenia Gravis Drugs Consumption Market Share by Application (2014-2019) 8 Myasthenia Gravis Drugs Major Manufacturers Analysis 8.1 Flamel Technologies 8.1.1 Flamel Technologies Myasthenia Gravis Drugs Production Sites and Area Served 8.1.2 Flamel Technologies Product Introduction, Application and Specification 8.1.3 Flamel Technologies Myasthenia Gravis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Roche 8.2.1 Roche Myasthenia Gravis Drugs Production Sites and Area Served 8.2.2 Roche Product Introduction, Application and Specification 8.2.3 Roche Myasthenia Gravis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Grifols 8.3.1 Grifols Myasthenia Gravis Drugs Production Sites and Area Served 8.3.2 Grifols Product Introduction, Application and Specification 8.3.3 Grifols Myasthenia Gravis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Pfizer 8.4.1 Pfizer Myasthenia Gravis Drugs Production Sites and Area Served 8.4.2 Pfizer Product Introduction, Application and Specification 8.4.3 Pfizer Myasthenia Gravis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Shire 8.5.1 Shire Myasthenia Gravis Drugs Production Sites and Area Served 8.5.2 Shire Product Introduction, Application and Specification 8.5.3 Shire Myasthenia Gravis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Novartis 8.6.1 Novartis Myasthenia Gravis Drugs Production Sites and Area Served 8.6.2 Novartis Product Introduction, Application and Specification 8.6.3 Novartis Myasthenia Gravis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Valeant 8.7.1 Valeant Myasthenia Gravis Drugs Production Sites and Area Served 8.7.2 Valeant Product Introduction, Application and Specification 8.7.3 Valeant Myasthenia Gravis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Alexion 8.8.1 Alexion Myasthenia Gravis Drugs Production Sites and Area Served 8.8.2 Alexion Product Introduction, Application and Specification 8.8.3 Alexion Myasthenia Gravis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 Catalyst 8.9.1 Catalyst Myasthenia Gravis Drugs Production Sites and Area Served 8.9.2 Catalyst Product Introduction, Application and Specification 8.9.3 Catalyst Myasthenia Gravis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 8.10 CSL 8.10.1 CSL Myasthenia Gravis Drugs Production Sites and Area Served 8.10.2 CSL Product Introduction, Application and Specification 8.10.3 CSL Myasthenia Gravis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.10.4 Main Business and Markets Served 8.11 Curavac 8.12 Cytokinetics 8.13 Galencia 8.14 GlaxoSmithKline 8.15 Lupin Pharmaceuticals 8.16 Mitsubishi Tanabe Pharma 9 Development Trend of Analysis of Myasthenia Gravis Drugs Market 9.1 Global Myasthenia Gravis Drugs Market Trend Analysis 9.1.1 Global Myasthenia Gravis Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Myasthenia Gravis Drugs Regional Market Trend 9.2.1 North America Myasthenia Gravis Drugs Forecast 2019-2025 9.2.2 Europe Myasthenia Gravis Drugs Forecast 2019-2025 9.2.3 China Myasthenia Gravis Drugs Forecast 2019-2025 9.2.4 Japan Myasthenia Gravis Drugs Forecast 2019-2025 9.2.5 Southeast Asia Myasthenia Gravis Drugs Forecast 2019-2025 9.2.6 India Myasthenia Gravis Drugs Forecast 2019-2025 9.3 Myasthenia Gravis Drugs Market Trend (Product Type) 9.4 Myasthenia Gravis Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Myasthenia Gravis Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Myasthenia Gravis Drugs Table Global Myasthenia Gravis Drugs Production (MT) Growth Rate Comparison by Types (2014-2025) Figure Global Myasthenia Gravis Drugs Production Market Share by Types in 2018 Figure Anticholinesterases Product Picture Figure Immunosuppressants Product Picture Figure Intravenous Immune Globulins Product Picture Table Global Myasthenia Gravis Drugs Consumption (MT) Comparison by Applications (2014-2025) Figure Global Myasthenia Gravis Drugs Consumption Market Share by Applications in 2018 Figure Hospitals Figure Clinics Figure Global Myasthenia Gravis Drugs Revenue (Million USD) (2014-2025) Figure Global Myasthenia Gravis Drugs Production (MT) (2014-2025) Figure North America Myasthenia Gravis Drugs Market Size (Million USD) (2014-2025) Figure Europe Myasthenia Gravis Drugs Market Size (Million USD) (2014-2025) Figure China Myasthenia Gravis Drugs Market Size (Million USD) (2014-2025) Figure Japan Myasthenia Gravis Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Myasthenia Gravis Drugs Market Size (Million USD) (2014-2025) Figure India Myasthenia Gravis Drugs Market Size (Million USD) (2014-2025) Table Myasthenia Gravis Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Myasthenia Gravis Drugs in 2018 Figure Manufacturing Process Analysis of Myasthenia Gravis Drugs Figure Industry Chain Structure of Myasthenia Gravis Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Myasthenia Gravis Drugs Manufacturing Plants Distribution Table Myasthenia Gravis Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Myasthenia Gravis Drugs Capacity (MT) of Major Manufacturers (2014-2019) Table Myasthenia Gravis Drugs Production (MT) of Major Manufacturers (2014-2019) Table Myasthenia Gravis Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Myasthenia Gravis Drugs Production Share by Manufacturers in 2018 Table Myasthenia Gravis Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Myasthenia Gravis Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Myasthenia Gravis Drugs Revenue Share by Manufacturers in 2018 Table Myasthenia Gravis Drugs Average Price (USD/Kg) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Myasthenia Gravis Drugs Production by Regions 2014-2019 (MT) Table Global Myasthenia Gravis Drugs Production Market Share by Regions 2014-2019 Figure Global Myasthenia Gravis Drugs Production Market Share by Regions in 2018 Table Global Myasthenia Gravis Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Myasthenia Gravis Drugs Revenue Market Share by Regions 2014-2019 Figure Global Myasthenia Gravis Drugs Revenue Market Share by Regions in 2018 Table Global Myasthenia Gravis Drugs Consumption by Regions 2014-2019 (MT) Table Global Myasthenia Gravis Drugs Consumption Market Share by Regions 2014-2019 Figure North America Myasthenia Gravis Drugs Production Growth Rate 2014-2019 (MT) Figure North America Myasthenia Gravis Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Myasthenia Gravis Drugs Production, Consumption Import and Export (MT) Figure Europe Myasthenia Gravis Drugs Production Growth Rate 2014-2019 (MT) Figure Europe Myasthenia Gravis Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Myasthenia Gravis Drugs Production, Consumption Import and Export (MT) Figure China Myasthenia Gravis Drugs Production Growth Rate 2014-2019 (MT) Figure China Myasthenia Gravis Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Myasthenia Gravis Drugs Production, Consumption Import and Export (MT) Figure Japan Myasthenia Gravis Drugs Production Growth Rate 2014-2019 (MT) Figure Japan Myasthenia Gravis Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Myasthenia Gravis Drugs Production, Consumption Import and Export (MT) Figure Southeast Asia Myasthenia Gravis Drugs Production Growth Rate 2014-2019 (MT) Figure Southeast Asia Myasthenia Gravis Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Myasthenia Gravis Drugs Production, Consumption Import and Export (MT) Figure India Myasthenia Gravis Drugs Production Growth Rate 2014-2019 (MT) Figure India Myasthenia Gravis Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Myasthenia Gravis Drugs Production, Consumption Import and Export (MT) Figure Global Consumption Myasthenia Gravis Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Myasthenia Gravis Drugs Market Share by Application (2014-2019) Table Flamel Technologies Myasthenia Gravis Drugs Production Sites and Area Served Table Flamel Technologies Myasthenia Gravis Drugs Product Introduction, Application and Specification Table Flamel Technologies Myasthenia Gravis Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Flamel Technologies Myasthenia Gravis Drugs Production Growth Rate (2014-2019) Table Flamel Technologies Myasthenia Gravis Drugs Production Market Share (2014-2019) Figure Flamel Technologies Myasthenia Gravis Drugs Revenue Market Share (2014-2019) Table Flamel Technologies Myasthenia Gravis Drugs Main Business and Markets Served Table Roche Myasthenia Gravis Drugs Production Sites and Area Served Table Roche Myasthenia Gravis Drugs Product Introduction, Application and Specification Table Roche Myasthenia Gravis Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Roche Myasthenia Gravis Drugs Production Growth Rate (2014-2019) Table Roche Myasthenia Gravis Drugs Production Market Share (2014-2019) Figure Roche Myasthenia Gravis Drugs Revenue Market Share (2014-2019) Table Roche Myasthenia Gravis Drugs Main Business and Markets Served Table Grifols Myasthenia Gravis Drugs Production Sites and Area Served Table Grifols Myasthenia Gravis Drugs Product Introduction, Application and Specification Table Grifols Myasthenia Gravis Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Grifols Myasthenia Gravis Drugs Production Growth Rate (2014-2019) Table Grifols Myasthenia Gravis Drugs Production Market Share (2014-2019) Figure Grifols Myasthenia Gravis Drugs Revenue Market Share (2014-2019) Table Grifols Myasthenia Gravis Drugs Main Business and Markets Served Table Pfizer Myasthenia Gravis Drugs Production Sites and Area Served Table Pfizer Myasthenia Gravis Drugs Product Introduction, Application and Specification Table Pfizer Myasthenia Gravis Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Pfizer Myasthenia Gravis Drugs Production Growth Rate (2014-2019) Table Pfizer Myasthenia Gravis Drugs Production Market Share (2014-2019) Figure Pfizer Myasthenia Gravis Drugs Revenue Market Share (2014-2019) Table Pfizer Myasthenia Gravis Drugs Main Business and Markets Served Table Shire Myasthenia Gravis Drugs Production Sites and Area Served Table Shire Myasthenia Gravis Drugs Product Introduction, Application and Specification Table Shire Myasthenia Gravis Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Shire Myasthenia Gravis Drugs Production Growth Rate (2014-2019) Table Shire Myasthenia Gravis Drugs Production Market Share (2014-2019) Figure Shire Myasthenia Gravis Drugs Revenue Market Share (2014-2019) Table Shire Myasthenia Gravis Drugs Main Business and Markets Served Table Novartis Myasthenia Gravis Drugs Production Sites and Area Served Table Novartis Myasthenia Gravis Drugs Product Introduction, Application and Specification Table Novartis Myasthenia Gravis Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Novartis Myasthenia Gravis Drugs Production Growth Rate (2014-2019) Table Novartis Myasthenia Gravis Drugs Production Market Share (2014-2019) Figure Novartis Myasthenia Gravis Drugs Revenue Market Share (2014-2019) Table Novartis Myasthenia Gravis Drugs Main Business and Markets Served Table Valeant Myasthenia Gravis Drugs Production Sites and Area Served Table Valeant Myasthenia Gravis Drugs Product Introduction, Application and Specification Table Valeant Myasthenia Gravis Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Valeant Myasthenia Gravis Drugs Production Growth Rate (2014-2019) Table Valeant Myasthenia Gravis Drugs Production Market Share (2014-2019) Figure Valeant Myasthenia Gravis Drugs Revenue Market Share (2014-2019) Table Valeant Myasthenia Gravis Drugs Main Business and Markets Served Table Alexion Myasthenia Gravis Drugs Production Sites and Area Served Table Alexion Myasthenia Gravis Drugs Product Introduction, Application and Specification Table Alexion Myasthenia Gravis Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Alexion Myasthenia Gravis Drugs Production Growth Rate (2014-2019) Table Alexion Myasthenia Gravis Drugs Production Market Share (2014-2019) Figure Alexion Myasthenia Gravis Drugs Revenue Market Share (2014-2019) Table Alexion Myasthenia Gravis Drugs Main Business and Markets Served Table Catalyst Myasthenia Gravis Drugs Production Sites and Area Served Table Catalyst Myasthenia Gravis Drugs Product Introduction, Application and Specification Table Catalyst Myasthenia Gravis Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Catalyst Myasthenia Gravis Drugs Production Growth Rate (2014-2019) Table Catalyst Myasthenia Gravis Drugs Production Market Share (2014-2019) Figure Catalyst Myasthenia Gravis Drugs Revenue Market Share (2014-2019) Table Catalyst Myasthenia Gravis Drugs Main Business and Markets Served Table CSL Myasthenia Gravis Drugs Production Sites and Area Served Table CSL Myasthenia Gravis Drugs Product Introduction, Application and Specification Table CSL Myasthenia Gravis Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table CSL Myasthenia Gravis Drugs Production Growth Rate (2014-2019) Table CSL Myasthenia Gravis Drugs Production Market Share (2014-2019) Figure CSL Myasthenia Gravis Drugs Revenue Market Share (2014-2019) Table CSL Myasthenia Gravis Drugs Main Business and Markets Served Table Curavac Myasthenia Gravis Drugs Production Sites and Area Served Table Cytokinetics Myasthenia Gravis Drugs Production Sites and Area Served Table Galencia Myasthenia Gravis Drugs Production Sites and Area Served Table GlaxoSmithKline Myasthenia Gravis Drugs Production Sites and Area Served Table Lupin Pharmaceuticals Myasthenia Gravis Drugs Production Sites and Area Served Table Mitsubishi Tanabe Pharma Myasthenia Gravis Drugs Production Sites and Area Served Figure Global Myasthenia Gravis Drugs Production (MT) Growth Rate Forecast 2019-2025 Figure Global Myasthenia Gravis Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Myasthenia Gravis Drugs Sales Price (USD/Kg) Forecast 2019-2025 Figure North America Myasthenia Gravis Drugs Production Growth Rate Forecast 2019-2025 (MT) Figure North America Myasthenia Gravis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Myasthenia Gravis Drugs Production Growth Rate Forecast 2019-2025 (MT) Figure Europe Myasthenia Gravis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Myasthenia Gravis Drugs Production Growth Rate Forecast 2019-2025 (MT) Figure China Myasthenia Gravis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Myasthenia Gravis Drugs Production Growth Rate Forecast 2019-2025 (MT) Figure Japan Myasthenia Gravis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Myasthenia Gravis Drugs Production Growth Rate Forecast 2019-2025 (MT) Figure Southeast Asia Myasthenia Gravis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Myasthenia Gravis Drugs Production Growth Rate Forecast 2019-2025 (MT) Figure India Myasthenia Gravis Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (MT) of Myasthenia Gravis Drugs by Type (2019-2025) Table Global Consumption (MT) of Myasthenia Gravis Drugs by Application (2019-2025) Table Myasthenia Gravis Drugs Distributors List Table Myasthenia Gravis Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Flamel Technologies Roche Grifols Pfizer Shire Novartis Valeant Alexion Catalyst CSL Curavac Cytokinetics Galencia GlaxoSmithKline Lupin Pharmaceuticals Mitsubishi Tanabe Pharma